The most influential Megatrends set to shape the world through 2030, identified by Euromonitor International, help businesses better anticipate market developments and lead change for their industries.
Learn moreEuromonitor addresses your unique questions and challenges across all B2B and B2C industries and geographies through custom, tailor-made research projects, designed to your specific goals.
Learn moreOct 2019
US$990Added to Cart
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
Portuguese consumers have been opting for stronger products, with this trend expected to continue over the forecast period. In an area reaching saturation, consumers are looking for faster and more efficient formulas.
Changing consumer lifestyles are having a positive impact on sales of some analgesics. For example, with a growing focus on health and wellness an increasing number of consumers are taking part in sport and physical activity which is resulting in more injuries.
Aspirin used to benefit from consumers looking to avoid having a stroke or a heart attack, with some consumers taking a daily dose of aspirin as a preventative measure. However, scientific studies have raised concerns over the benefits versus the risks of taking a daily dose of aspirin amongst healthy consumers, with it being linked to the risk of internal bleeding among other serious side effects.
GSK Consumer Healthcare increased its lead in analgesics in 2019 largely thanks to the dynamic growth of its Voltaren 25 brand in adult diclofenac. This is the only OTC brand authorised for sale in this category in Portugal.
Over the forecast period there is expected to be further segmentation driven by specific positioning such as for normal or strong headaches, menstrual pain, cervical pain, muscular pain, and rheumatic or joint pain. Marketing campaigns and communication will be important to set this positioning and brand image, with this strategy expected to have a positive impact on acetaminophen, ibuprofen and diclofenac.
Bene Farmacêutica Lda launched its 400mg range of ibuprofen in 2019 under the Ib-u-ron brand. The company is already well-known and trusted with its Ben-u-ron range of acetaminophen, which has ensured that Ib-u-ron made a strong entry.
Files are delivered directly into your account within a few minutes of purchase.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.
Delivery: Files are delivered directly into your account within a few minutes of purchase.
Overview
Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Portugal with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Analgesics industry in Portugal, our research will save you time and money while empowering you to make informed, profitable decisions.
The Analgesics in Portugal market research report includes:
Our market research reports answer questions such as:
Why buy this report?
This industry report originates from Passport, our Consumer Health market research database.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.